LivaNova (NASDAQ:LIVN) Price Target Increased to $62.00 by Analysts at Robert W. Baird

LivaNova (NASDAQ:LIVN – Get Free Report) had its price objective boosted by equities research analysts at Robert W. Baird from $56.00 to $62.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Robert W. Baird’s price objective indicates a potential upside of 10.89% from the company’s […]

Related Keywords

Robertw Baird , ,Barclays Plc ,Livanova Company Profile ,Voloridge Investment Management ,Pricet Rowe Associates Inc ,Nuveen Asset Management ,Needham Company ,Get Free Report ,Nova Trading Down ,Investment Management ,Asset Management ,Advanced Circulatory ,Livanova Daily ,Livanova ,Nasdaq Livn ,Livn ,Medical ,Boost Price Target ,